12 November 2021: Original Paper
Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study
Alejandro Muñoz Serrano 1ABDEF* , Ana Arias 1ABDE , Víctor Moreno-Torres 1BE , Jorge Calderón 1B , Natalia Vicente 2DE , Valentín Cuervas-Mons 13ADEFDOI: 10.12659/AOT.933152
Ann Transplant 2021; 26:e933152
Table 3 Primary and secondary outcomes.
| All patients (N=116) | SOT-recipients (N=32) | No-SOT patients (N=84) | p | |
|---|---|---|---|---|
| Mortality (%) | 11 (9.5) | 7 (21.9) | 4 (4.8) | |
| Severe ARDS (%) | 37 (31.9) | 9 (28.1) | 28 (33.3) | 0.59 |
| Days of hospitalization | 10.5 [6–17] | 8.5 [5.5–21] | 11.5 [6.5–16.5] | 0.34 |
| Results are expressed as mean±standard deviation and number (percentage). ARDS – acute respiratory distress syndrome. | ||||